Durability of clinical benefit and biomarkers in patients with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib). CodeBreaK 100 is an important, multicenter, […]
The efficacy of olaparib as maintenance therapy in newly diagnosed advanced ovarian cancer with BRCA mutation: 5-year follow-up from SOLO-1 trial Patients with newly diagnosed advanced […]